Stora Enso’s Capital Markets Day takes place in Helsinki on Wednesday 7 November. The theme of the day is “Creating value in the bioeconomy”.
“I am pleased how Stora Enso demonstrates ability to create value in the bioeconomy and successfully delivers sustainable profitable growth. We are perfectly positioned to benefit from the global megatrends, as we see many new opportunities for our renewable products to replace fossil-based materials,” says CEO Karl-Henrik Sundström.
During the day, Stora Enso will present its strategy and all five business divisions.
Capital expenditure for 2019
Stora Enso maintains its capital expenditure (excluding investments to biological assets) at the level of depreciation. In 2019, the estimated capital expenditure will be EUR 550–600 million, including EUR 100 million for biological assets. The forecasted annual depreciation is EUR 490–510 million and operational decrease in the value of biological assets EUR 50–70 million. Capital expenditure amounts do not include potential acquisitions or divestments and are excluding the impact of IFRS 16 Leases.
www.storaenso.com
